V. Suman

发表

Molecular markers in male breast carcinoma

J. Donohue, J. Ingle, C. Erlichman, 1998, Cancer.

CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations

M. Beckmann, P. Fasching, R. Altman, 2013, Clinical pharmacology and therapeutics.

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial

L. Trani, O. Griffith, M. Ellis, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.

E. Perez, J. Ingle, J. Kugler, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

HER2 testing by local, central, and reference laboratories in the NCCTG N9831 Intergroup Adjuvant Trial.

E. Perez, S. Martino, D. Visscher, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.

E. Perez, K. Rowland, S. Alberts, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Interim cardiac safety analysis of NCCTG N9831 Intergroup adjuvant trastuzumab trial

B. Gersh, E. Perez, A. Jaffe, 2005 .

Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer

E. Perez, S. Martino, N. Wolmark, 2007 .

Abstract PD07-01: Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 study of Triage to Chemotherapy Based on 2 to 4 week Ki67 level > 10%.

J. Olson, G. Babiera, M. Watson, 2012 .

Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.

R. Greil, R. Weinshilboum, Xiao-Jun Ma, 2009 .

ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer.

J. Olson, G. Babiera, K. Hunt, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study.

J. Krook, J. Kugler, S. Nair, 1998, American journal of clinical oncology.

Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma.

R. Marks, W. Maples, V. Suman, 1997, American journal of clinical oncology.

Tamoxifen pharmacogenetics ofCYP2D6, CYP2C19, andSULT1A1: long term follow-up of the North Central Cancer Treatment Group 89-30-52 adjuvant trial.

R. Weinshilboum, J. Black, C. Reynolds, 2009 .

Metaplastic breast cancer: prognosis and response to systemic therapy.

J. Ingle, A. Adjei, V. Suman, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.

K. Rowland, H. Pitot, V. Suman, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Trial of Autologous Hematopoietic Stem Cell Transplantation with Escalating Doses of Topotecan Combined with Cyclophosphamide and Carboplatin in Patients with Relapsed or Persistent Ovarian or Primary Peritoneal Carcinoma

A. Dispenzieri, V. Suman, S. Ansell, 2009, Bone Marrow Transplantation.

A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma.

W. Maples, V. Suman, E. Creagan, 1998, American Journal of Clinical Oncology.

Phase II trial of the mTOR inhibitor everolimus (RAD-001) in metastatic melanoma.

H C Pitot, V J Lowe, V. Lowe, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen.

C. Vachon, C. Scott, J. Olson, 2007, Breast.

A randomized trial of interferon‐alpha in cervical dysplasia

J. A. Jefferies, V. Suman, R. Morton, 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.

L. Trani, O. Griffith, M. Ellis, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Quantitative assessment of tumor-infiltrating neutrophils to predict immunotherapy responses in metastatic melanoma.

T. Flotte, R. McWilliams, S. Markovic, 2019, Journal of Clinical Oncology.

OT2-05-06: ACOSOG Z11101/ACRIN 6694: Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer.

R. Birdwell, C. Gatsonis, G. Newstead, 2011 .

Abstract S5-5: Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831

E. Winer, S. Martino, G. Sledge, 2012 .